AI Is Already Reshaping How CME Gets Written
Earlier coverage of accreditation operations and its implications for CME providers.
Hematology-oncology clinicians cite ABIM fees over $2,000, fax-only processes, and privileging risks, creating demand for low-friction MOC activities and hybrid AI advocacy training.
Oncology clinicians this week described ABIM certification as a direct barrier to practice, citing fees over $2,000, fax-only deactivation, and hospital bylaws that tie privileges to board status. The signal points to an immediate opportunity for CME providers to reduce credentialing friction and support hybrid AI use in advocacy.
The MOC conversation sharpened from general frustration into operational detail. In one widely discussed thread, an oncologist described a certification problem that threatened hospital privileges, saying, “Hospital bylaws require me to be board certified.” The same thread described paying more than $2,000 and navigating a process that included deactivating a board by fax rather than through a clean online workflow (source).
That matters because clinicians are not separating “education” from the systems that convert education into usable credit. A second post framed the consequence more directly: after paying more than $2,000, the physician said he was again considered able to provide care, while also noting he had paid to avoid losing privileges at his hospital (source).
The CME implication is not simply “offer more MOC.” It is that credential-linked learning has to behave like infrastructure. If a clinician completes education but still has to guess whether it counts, chase certificates, or manually transmit points, the provider has not solved the learner’s problem.
We saw a related pattern in an earlier brief on MOC frustration and new certifying boards, but this week added sharper administrative evidence: fees, privileging risk, specialty-board dependency, and low-trust submission mechanics. In another oncology thread, a physician asked for ways to earn CME/MOC points from work already being done — “Think things you are already doing that I may not be thinking of?” — and then noted that general CME without ABIM MOC points was not enough (source).
For CME teams, the question is now concrete: where can you remove steps between learning, credit, reporting, and proof?
The AI signal was narrower but useful. Clinicians are not only talking about AI for summarizing articles or generating teaching content; they are testing it in administrative advocacy. One oncologist described asking ChatGPT to draft a letter to hospital administrators arguing against ABIM certification as a requirement, then asking for a stronger tone (source).
That is not a mature practice standard. It is an early workflow clue. When clinicians use AI to draft letters about privileges, appeals, or medical necessity, the risk is not just factual accuracy. It is tone, institutional context, evidence selection, privacy, and whether a human owner reviews the output before it leaves the clinician’s hands.
A related oncology advocacy discussion made the same hybrid model more explicit. The conversation included use of open-access LLM tools to help patients and care partners draft appeal or medical-necessity letters, with the draft then passed to a nurse navigator or clinician for refinement. The stated goal was not a perfect AI-generated letter, but faster team-based work that still involved human review (source).
For CME providers, the opportunity is not a generic AI course. It is short, scenario-based training around the handoff: what AI can draft, what the clinician must verify, what evidence must be attached, and what should never be delegated. The useful question is: can your AI education teach clinicians where to place the human checkpoint, not just how to write a better prompt?
The next competitive edge for CME providers will not be more content alone. It will be reducing the administrative drag around learning and helping clinicians use new tools without losing accountability. This week’s clinician conversation points to the same underlying demand from two directions: make required learning easier to convert into professional standing, and make AI-supported work safer to use in real administrative battles. CME teams that treat both as workflow problems will be closer to how clinicians are already making decisions.
Documents $2k+ fees and lack of online deactivation process, forcing fax submissions.
"Now I decided to let my internal medicine board lapse (which I took in 2014) as I am a specialized BMT doc (so it lasted until 1/1/24). However, I took my hematology and oncology boards in 2017 (and they should not lapse until 2027) I called the ABIM and asked what's up???"
Show captured excerptCollapse excerptHighlights hospital bylaws tying privileges to ABIM certification despite clinician preference to let it lapse.
Earlier coverage of accreditation operations and its implications for CME providers.
Earlier coverage of accreditation operations and its implications for CME providers.
Earlier coverage of accreditation operations and its implications for CME providers.
ChatCME surfaces the questions clinicians actually ask — so you can build activities that close real knowledge gaps.
Request a demo"Great news, magically after giving over 2 grand to ABIM I am deemed worthy of providing care to patients again! Thank you ABIM! @doctorwes"
Explicit interest in NBPAS as cheaper, physician-led alternative pathway.
"Ok #medtwitter what are you favorite ways to earn CME/MOC points. Other than Uptodate? Think things you are already doing that I may not be thinking of? I am not happy I have to pay into this scam and still think all fees should be abolished! #onctwitter"
Show captured excerptCollapse excerptClinicians using ChatGPT to draft letters challenging hospital ABIM policies.
"ChatGPT AI wants hospitals to drop ABIM! I asked ChatGPT to write a letter to hospital admins to remove ABIM certification as a requirement to work. It's first try was too nice so I asked it to make it angrier. It did a great job. I love AI!"
Show captured excerptCollapse excerptPoll and discussion showing majority preference for combined AI + human intelligence in oncology settings.
Open sourceDetails activity-by-activity approval, local partner mandates, lead times, costs, and cultural requirements for European expansion.
Open sourceAdvocates curiosity over reassurance for 'I hate Sim' reactions and pairing simulation with real-world audit/FMEA data.
Open source